- Joined
- Jul 28, 2005
- Messages
- 101
- Reaction score
- 0
Research Goes On!!
The Osteopathic Research Center, a national research organization housed at the University of North Texas Health Science Center Texas College of osteopathic Medicine, received $900,000 in renewing funds for the next four years. The ORC has made progress beyond our expectations, said Scott Stoll, DO, PhD, executive director of the ORC. We are elated that the profession recognizes these accomplishments and has entrusted us for another four years to build upon our prior success to the benefit of the osteopathic profession. Founded in 2001, the Osteopathic Research Center was developed with an initial investment of $1.1 million over a four-year period (2002-2005) from the American Osteopathic Foundation, the American Osteopathic Association, and the American Association of Colleges of Osteopathic Medicine. These same osteopathic organizations have renewed funding for the ORC, bringing the total investment to $2 million for the eight-year period. The refunding of the ORC again demonstrates the excellence and importance of the research being done, said Ronald Blanck, DO, president of the health science center. This reflects well on the health science center and the osteopathic profession. The ORC works to increase evidence-based knowledge about the mechanisms of action and clinical efficacy of osteopathic manipulative medicine through research, training, and conducting local and national research. Funds are dedicated to building
osteopathic manipulative medicine research capabilities across all colleges of osteopathic medicine, Dr. Stoll said. Funded research projects include the use of OMM during pregnancy and in treating diabetes, pneumonia, back pain, autonomic neural function and lymph flow. Unfunded projects include collecting pilot data in the areas of OMM and Carpal Tunnel Syndrome, chronic obstructive pulmonary disease, immune function and recovery after knee arthroscopy. The ORC staff includes Dr. Stoll; Hollis King, DO, PhD, associate executive director; Michael Smith, PhD, research core director; John Licciardone, DO, MBA, director of clinical research; Daisha Cipher, PhD, biostatistics core director; des Anges Cruser, PhD, MPA,administrative director; Krista Thrasher, senior editorial assistant; Heather Denney, MPA, research project manager; Kimberly Fulda, MPH, research project manager; and Asma Salam, MD, clinical research coordinator.
The Osteopathic Research Center, a national research organization housed at the University of North Texas Health Science Center Texas College of osteopathic Medicine, received $900,000 in renewing funds for the next four years. The ORC has made progress beyond our expectations, said Scott Stoll, DO, PhD, executive director of the ORC. We are elated that the profession recognizes these accomplishments and has entrusted us for another four years to build upon our prior success to the benefit of the osteopathic profession. Founded in 2001, the Osteopathic Research Center was developed with an initial investment of $1.1 million over a four-year period (2002-2005) from the American Osteopathic Foundation, the American Osteopathic Association, and the American Association of Colleges of Osteopathic Medicine. These same osteopathic organizations have renewed funding for the ORC, bringing the total investment to $2 million for the eight-year period. The refunding of the ORC again demonstrates the excellence and importance of the research being done, said Ronald Blanck, DO, president of the health science center. This reflects well on the health science center and the osteopathic profession. The ORC works to increase evidence-based knowledge about the mechanisms of action and clinical efficacy of osteopathic manipulative medicine through research, training, and conducting local and national research. Funds are dedicated to building
osteopathic manipulative medicine research capabilities across all colleges of osteopathic medicine, Dr. Stoll said. Funded research projects include the use of OMM during pregnancy and in treating diabetes, pneumonia, back pain, autonomic neural function and lymph flow. Unfunded projects include collecting pilot data in the areas of OMM and Carpal Tunnel Syndrome, chronic obstructive pulmonary disease, immune function and recovery after knee arthroscopy. The ORC staff includes Dr. Stoll; Hollis King, DO, PhD, associate executive director; Michael Smith, PhD, research core director; John Licciardone, DO, MBA, director of clinical research; Daisha Cipher, PhD, biostatistics core director; des Anges Cruser, PhD, MPA,administrative director; Krista Thrasher, senior editorial assistant; Heather Denney, MPA, research project manager; Kimberly Fulda, MPH, research project manager; and Asma Salam, MD, clinical research coordinator.
